HASSANEIN WALEED H (President & CEO) purchased 1.8% of their position (8.78K shares) of TRANSMEDICS GROUP, INC. on the open market
Open‑market purchase worth $1.00M — a small addition. The strongest form of insider conviction signal.
P · 1 purchase
Filed: 11/18/2025ACC: 0001193125-25-286229
DirectorOfficer· President & CEO
Since May 2019
+8.78K
Net shares
Net buyer
$1.00M
Total acquired
1
Open market trades
1B · 0S
1
Total transactions
8.78K acquired
Non-Derivative Transactions1
Common Stock
Indirect
Shares
+8.78K
Price / share
$114.00
Trade value
$1M
% of position
1.8%
11/17/2025
486.23K→495.01K
Total
Net shares
+8.78K
Net value
$1M
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Indirect | 11/17/2025 | P · Purchase | +8.78K | $114.00 | $1M | 1.8% | 486.23K | 495.01K |
| Total | +8.78K | $1M | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)1
Common Stock
DirectShares owned121.42K
Total
121.42K direct121.42K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 121.42K | Direct |
| Total | 121.42K | 121.42K direct |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported